Trends in invasive Haemophilus influenzae serotype a disease in England from 2008-09 to 2021-22: a prospective national surveillance study

被引:9
|
作者
Bertran, Marta [1 ]
DAeth, Joshua C. [2 ]
Hani, Erjola [1 ]
Amin-Chowdhury, Zahin [1 ]
Fry, Norman K. [2 ]
Ramsay, Mary E. [1 ]
Litt, David J. [2 ]
Ladhani, Shamez N. [1 ,3 ]
机构
[1] UK Hlth Secur Agcy, Immunisat Dept, London NW9 5EQ, England
[2] UK Hlth Secur Agcy, Resp & Vaccine Preventable Bacteria Reference Unit, London, England
[3] St Georges Univ London, Paediat Infect Dis Res Grp, London, England
来源
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 10期
关键词
MOLECULAR EPIDEMIOLOGY; A DISEASE; SEROTYPE; CARRIAGE; CHILDREN; VACCINE;
D O I
10.1016/S1473-3099(23)00188-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Invasive Haemophilus influenzae serotype a (Hia) disease is rare, with most cases reported among Indigenous populations in North America. In England, national surveillance was enhanced following an increase in laboratory-confirmed invasive Hia disease since the 2016-17 epidemiological year. This study aimed to describe the epidemiological trends, clinical characteristics of cases, and assess potential genomic drivers.Methods Hospital laboratories in England routinely submit invasive H influenzae isolates to the UK Health Security Agency for confirmation and serotyping. In this prospective national surveillance study we contacted the general practitioners and clinicians of all patients with laboratory-confirmed invasive Hia from the 2008-09 to the 2021-22 epidemiological year to complete a clinical questionnaire on demographics, underlying conditions, clinical presentation, complications, outcomes, and travel history of the patient. All Hia invasive isolates from residents in England were included in the study; non-invasive isolates were excluded. Multilocus sequence typing (MLST), whole genome single-nucleotide polymorphism, and k-mer-based analysis of bacterial isolates were performed following Illumina whole-genome sequencing (WGS). Outcomes included epidemiological trends, clinical characteristics of confirmed Hia cases, and genomic analyses.Findings From the 2008-09 to the 2021-22 epidemiological years, there were 52 cases of invasive infection with H influenzae serotype a in England (25 [48%] in female patients and 27 [52%] in male patients). There were zero to two annual Hia cases (accounting for <0.5% of serotyped H influenzae isolates) until 2015-16, after which cases increased across England to 19 cases in 2021-22 (incidence 0.03 cases per 100 000), when Hia accounted for 19 (4%) of 484 serotyped H influenzae isolates, 19 (19%) of 100 capsulated cases, and 37% (19 of 52) of all H influenzae cases between 2008-09 and 2021-22. Most of the recent increase in cases occurred among individuals aged 65 years and older (17 [33%] of 52), who typically presented with bacteraemic pneumonia (13 [76%] of 17), and infants younger than 1 year, who had the highest incidence and were more likely to present with meningitis (five [50%] of ten). Overall case fatality rate was 7.7% (95% CI 2.1-19.7; four of 52 patients). WGS found that closely related MLST sequence types ST1511 (20 [39%] of 51), ST23 (13 [25%] of 51), and ST56 (seven [14%] of 51) accounted for most cases, with no evidence of serotype b strains switching capsule to Hia. Duplication of the capsule operon, associated with more severe disease, was present in 32 (80%) of 40 of these sequence types. Analysis of the core and accessory genome content grouped most isolates into a single strain.Interpretation The persistent increase in invasive Hia cases across England and across all age groups suggests widespread transmission, consistent with reports from other European countries, and will require close monitoring. Crown Copyright (c) 2023 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
引用
收藏
页码:1197 / 1206
页数:10
相关论文
共 9 条
  • [1] Trends in invasive Haemophilus influenzae serotype b (Hib) disease in England: 2012/13 to 2022/23
    Hani, Erjola
    Abdullahi, Fariyo
    Bertran, Marta
    Eletu, Seyi
    D'Aeth, Joshua
    Litt, David J.
    Fry, Norman K.
    Ladhani, Shamez N.
    JOURNAL OF INFECTION, 2024, 89 (04)
  • [2] Nontypeable Haemophilus influenzae Invasive Disease in the Netherlands: A Retrospective Surveillance Study 2001-2008
    van Wessel, Karen
    Rodenburg, Gerwin D.
    Veenhoven, Reinier H.
    Spanjaard, Lodewijk
    van der Ende, Arie
    Sanders, Elisabeth A. M.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (01) : E1 - E7
  • [3] Trends in serotype distribution and antimicrobial susceptibility pattern of invasive Haemophilus influenzae isolates from Brazil, 2009-2021
    Zanella, Rosemeire Cobo
    Bokermann, Sergio
    Galhardo, Marta
    Gava, Caroline
    Almeida, Samanta Cristine Grassi
    Pereira, Gabriela Andrade
    de Lemos, Ana Paula Silva
    INTERNATIONAL MICROBIOLOGY, 2025, 28 (01) : 157 - 163
  • [4] Prevalence of Haemophilus influenzae in the nasopharynx of children from regions with varying incidence of invasive H. influenzae serotype a disease: Canadian Immunization Research Network (CIRN) study
    Ulanova, Marina
    Tsang, Raymond S. W.
    Goldfarb, David M.
    Smieja, Marek
    Huska, Brenda
    Luinstra, Kathy
    Le Saux, Nicole
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2024, 83 (01)
  • [5] Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of serotype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) Study
    Cerqueira, Ashley
    Byce, Sarah
    Tsang, Raymond S. W.
    Jamieson, Frances B.
    Kus, Julianne V.
    Ulanova, Marina
    CANADIAN JOURNAL OF MICROBIOLOGY, 2019, 65 (11) : 805 - 813
  • [6] Characteristics of children with invasive pneumococcal disease eligible for the 1+1 compared with the 2+1 PCV13 infant immunisation schedule in England: a prospective national observational surveillance study
    Abdullahi, Fariyo
    Bertran, Marta
    D'Aeth, Joshua C.
    Eletu, Seyi
    Chan, Yung-Wai
    Andrews, Nick J.
    Litt, David J.
    Ramsay, Mary E.
    Ladhani, Shamez N.
    LANCET CHILD & ADOLESCENT HEALTH, 2024, 8 (11): : 788 - 797
  • [7] Invasive pneumococcal disease 3 years after introduction of a reduced 1+1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study
    Bertran, Marta
    D'Aeth, Joshua C.
    Abdullahi, Fariyo
    Eletu, Seyi
    Andrews, Nick J.
    Ramsay, Mary E.
    Litt, David J.
    Ladhani, Shamez N.
    LANCET INFECTIOUS DISEASES, 2024, 24 (05): : 546 - 556
  • [8] Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
    Ouldali, Naim
    Varon, Emmanuelle
    Levy, Corinne
    Angoulvant, Francois
    Georges, Scarlett
    Ploy, Marie-Cecile
    Kempf, Marie
    Cremniter, Julie
    Cohen, Robert
    Bruhl, Daniel Levy
    Danis, Kostas
    LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 137 - 147
  • [9] Invasive pneumococcal disease 3 years after introduction of a reduced 1+1 infant 13valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study (vol 24, pg 546, 2024)
    Huang, C.
    Peng, Y.
    Zhang, Y.
    LANCET INFECTIOUS DISEASES, 2024, 24 (06): : e356 - e356